Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Coverage denials delay treatment at exactly the moment when dementia patients can least afford it. When insurance companies reject or postpone coverage for diagnostic tests, medications, or cognitive therapies, the disease continues advancing undetected or untreated—shrinking the narrow window when early intervention could slow progression. For someone showing signs of cognitive decline, a six-month delay in getting an MRI or neuropsychological evaluation means the disease has progressed further, sometimes past the point where certain medications could have helped. This article examines why coverage denials happen, how they specifically threaten dementia patients, what you can do when denied, and how to build a stronger case against insurers who delay necessary care.
Dementia is not a condition where “we’ll deal with it next year” is a viable strategy. The brain changes are cumulative and largely irreversible. A coverage denial that forces a three-month appeals process can mean the difference between a diagnosis at stage 1 and a diagnosis at stage 2—where cognitive loss has already become more pronounced and treatment options are more limited. We’ll explore the mechanisms behind these denials, the specific harms they cause in brain health management, and concrete steps to fight back.
Table of Contents
- How Insurance Companies Create Barriers to Dementia Diagnosis and Early Treatment
- The Cognitive Cost of Treatment Delays in Progressive Brain Disease
- Caregiver Burden Escalates When Diagnosis Is Delayed by Insurance Barriers
- How to Successfully Appeal Coverage Denials and Restore Access to Necessary Testing
- When Insurance Companies Reject Appeals and You Must Escalate
- Self-Pay Options and When They Make Sense
- Systemic Change and Advocacy for Faster Coverage Pathways
- Conclusion
- Frequently Asked Questions
How Insurance Companies Create Barriers to Dementia Diagnosis and Early Treatment
Insurance denials in dementia care typically follow a few predictable patterns. The insurer claims the test is “not medically necessary,” that you haven’t exhausted cheaper alternatives first (like a basic cognitive screening in your primary care office), or that you need prior authorization from a specialist you don’t yet have access to—creating a bureaucratic loop. For example, an insurance company might deny coverage for a PET scan to evaluate early cognitive impairment, arguing that an MRI “should be tried first,” even though these are different tests that answer different diagnostic questions. The insurer isn’t making a medical judgment; it’s making a financial one, betting that some patients will simply give up rather than fight.
The problem intensifies because dementia evaluation often requires multiple specialized providers—a neurologist, sometimes a neuroradiologist, possibly a neuropsychologist—and many insurance plans require separate authorizations for each. A 75-year-old with memory concerns may need approval for the initial neurology consultation (which takes 4-6 weeks to schedule), then approval for cognitive testing (another 2-week wait), then approval for imaging. By the time all approvals come through, you’re three months into a process that should take six weeks. The disease hasn’t stopped advancing during those delays.
The Cognitive Cost of Treatment Delays in Progressive Brain Disease
Unlike many health conditions where a three-month delay is an inconvenience, dementia is progressive by definition. Neurons are dying. Connections are being lost. That time is not recoverable. When someone is finally diagnosed at a later stage due to approval delays, the medications and interventions available are often less effective.
Cholinesterase inhibitors like donepezil work best when started early, ideally before significant cognitive loss has occurred; their effectiveness diminishes as disease advances. A patient denied early diagnosis may miss the window where these drugs could meaningfully slow decline. However, if the delay occurs in someone with mild cognitive impairment (MCI) but they’re not yet progressing to dementia, the impact differs slightly—though still serious. Someone with stable MCI might benefit from earlier cognitive rehabilitation and lifestyle interventions that can slow progression. A coverage denial that delays access to cognitive training or a neuropsychological assessment (which identifies specific cognitive strengths and weaknesses to target) means missing months where these preventive approaches might have the most impact. The denial doesn’t just delay a diagnosis; it delays the entire therapeutic window.
Caregiver Burden Escalates When Diagnosis Is Delayed by Insurance Barriers
Family members living with a person experiencing undiagnosed cognitive decline face months of uncertainty. Is the memory loss normal aging or dementia? Should they be planning for long-term care? Can the person still manage finances safely? insurance denials that delay diagnosis also delay the moment when families can access caregiver support, respite care programs, or cognitive rehabilitation services. A spouse might spend a year managing a person with undiagnosed dementia without any support because the diagnosis isn’t official yet—no care plan, no resources, no relief.
When diagnosis finally comes after a coverage denial and appeals process, families are often further along in crisis. The person may have already had a fall or accident due to unrecognized cognitive impairment, made poor financial decisions, or lost more independence than they might have with earlier support. The caregiver is burned out, resentful, and depleted. Early diagnosis—which coverage denials prevent—would have allowed families to plan, prepare, and access support services while they still had time to adjust.
How to Successfully Appeal Coverage Denials and Restore Access to Necessary Testing
The first step is understanding that denials are often arbitrary barriers, not final medical judgments. When your insurance company denies coverage for a neuropsychological evaluation or MRI, you have the right to appeal. Request the written denial in full and look for the specific reason: “not medically necessary,” “requires prior authorization,” “excludes diagnostic tests,” or “exceeds frequency limits.” Each reason requires a different response strategy. For “not medically necessary” denials, gather documentation of medical necessity from your physician. Have your doctor write a letter stating specifically why this test is essential for your care—not “to evaluate memory” but “to differentiate between normal aging and mild cognitive impairment, which will determine whether medication or cognitive rehabilitation is appropriate.” Include any cognitive screening results (even informal ones) that suggest concerns. Include your age, symptom duration, and family history of dementia if applicable. Insurance medical reviewers pay attention to concrete clinical indicators, not vague complaints.
If your primary care doctor performed the Montreal Cognitive Assessment or another screening tool and found abnormalities, that becomes powerful evidence. If you don’t have that documentation, ask your doctor to perform screening now so you have baseline data for your appeal. For prior authorization requirements, don’t wait passively. Call the insurance company, get the authorization requirement in writing, and ask exactly what documentation they need to approve. Sometimes they’ll approve it immediately if you provide the right forms and physician attestation. Other times they’ll demand consultation with a specific type of specialist first. If that’s the case, ask whether your primary care doctor’s referral is sufficient, or whether you need a neurologist’s order. Some insurance plans will approve faster if the request comes from a neurologist rather than a primary care doctor, even for the same test.
When Insurance Companies Reject Appeals and You Must Escalate
Some insurers will deny appeals with boilerplate responses that don’t address your specific medical evidence. This is where external appeals and state insurance commissioner complaints become necessary. After the insurer’s internal appeal is denied, you have the right to request an independent external review—a medical professional outside the insurance company evaluates whether the denial was appropriate. This costs nothing and often succeeds where internal appeals fail, because external reviewers are slightly more willing to prioritize patient care over cost containment.
However, external reviews still take time—typically 30-45 days—which is time your brain is not being evaluated. While the appeal is pending, ask your doctor whether there’s a lower-cost alternative that insurance will approve immediately, just to start the evaluation process. For example, if insurance denies the PET scan, can your doctor order an MRI first? It won’t answer all the same questions, but it may identify treatable causes of cognitive decline (like stroke or tumor) while you fight for approval of more sophisticated imaging. This isn’t ideal—you’re essentially letting insurance dictate your diagnostic pathway—but it keeps the process moving while you appeal.
Self-Pay Options and When They Make Sense
Some families choose to pay out-of-pocket for testing that insurance denies, rather than wait through appeals. A neuropsychological evaluation typically costs $1,500-$3,000. A PET scan might cost $3,000-$5,000 without insurance. An MRI is usually $1,000-$2,500. For families with savings or the ability to finance these costs, self-pay can accelerate diagnosis by months.
Once you have private testing results, you can often submit them to insurance for coverage decisions on follow-up care (medication, therapies) that are supported by your now-official diagnosis. The tradeoff: you’re paying for a diagnosis that insurance should have already covered. But if the insurance denial process would take four months and cost you the therapeutic window for early intervention, paying out-of-pocket for testing now might preserve treatment options that would be lost if you waited. Discuss this calculation with your doctor. If early diagnosis would actually change treatment, self-pay is worth considering. If the evaluation is more about establishing baseline for a diagnosis you’re fairly certain of already, waiting for approval might be reasonable.
Systemic Change and Advocacy for Faster Coverage Pathways
Individual appeals help individual patients, but the systemic problem persists: insurance companies profit from delayed diagnosis and treatment. Some states and advocacy organizations are pushing for “dementia-specific” insurance policies that recognize the unique time-sensitivity of brain disease. A few insurers now offer expedited review pathways for cognitive decline and dementia-related care, acknowledging that delays cause irreversible harm.
If your insurance offers an expedited pathway, use it. At the policy level, there’s growing recognition that denying early diagnostic testing in dementia care is actually more expensive long-term—missed early intervention leads to faster progression, earlier institutionalization, and higher total costs. But that financial argument doesn’t help a patient right now. Your best tools are persistence in appeals, documentation from your doctor, and willingness to involve state regulators if insurance continues denying medically necessary care.
Conclusion
Coverage denials in dementia care are not neutral delays—they actively harm patients by pushing diagnosis and treatment into later disease stages where interventions are less effective. When your insurance company denies coverage for cognitive testing, diagnosis, or dementia-related care, understand that you can appeal, that external reviews exist, and that your doctor’s documentation of medical necessity matters. The goal is to shorten the approval timeline as much as possible, even if that means accepting a lower-cost diagnostic test first while fighting for more comprehensive evaluation. Your next step: If you’re facing a coverage denial, ask your doctor to document the specific medical reason this test is needed right now.
Gather any cognitive screening results or symptoms that support that need. File a formal appeal with the insurance company within the timeframe they specify (usually 30-180 days, depending on your plan). If the internal appeal fails, request an external review. Dementia doesn’t wait for insurance approvals, and neither should you.
Frequently Asked Questions
Can my doctor’s office help me appeal an insurance denial?
Yes. Most offices have staff who handle insurance appeals regularly. They know which documentation insurers respond to and can submit appeals on your behalf. Ask your neurologist or primary care office for their appeals process. Some offices will pursue appeals aggressively; others are passive. If your office doesn’t prioritize appeals, consider getting a second opinion from a neurologist who will fight for necessary testing.
How long does an external review typically take?
External reviews usually take 30-45 days, though urgent or expedited reviews (for serious conditions like dementia) can sometimes be completed in 10-15 days. Ask the insurance company if your case qualifies for expedited external review based on medical urgency.
Will the test be covered if I pay out-of-pocket and then appeal?
Sometimes. If you pay privately and get results, you can submit those results to insurance as evidence that testing was necessary and appropriate. Insurance may then cover follow-up care (like medication or therapy) even if they won’t reimburse the private test. Get a detailed report from your testing facility that you can submit to insurance.
What if my insurance says the test is “not medically necessary”?
Ask for the written policy or clinical guidelines they’re using to make that determination. Challenge it with evidence: your doctor’s assessment, any cognitive screening results, symptom duration, risk factors, and age. Many “not medically necessary” denials are based on outdated guidelines or arbitrary cost-cutting rather than actual medical standards. Your doctor’s written explanation of why the test is necessary can reverse these denials in appeals.
Can I see a neurologist without waiting for insurance approval?
Yes, but it may cost more. If you pay out-of-pocket for the neurologist visit, you can then have the neurologist order imaging or testing that might be approved by insurance with their specialist recommendation. Some insurance plans approve faster when requests come from specialists. This costs money upfront but might save time.
What should I do if insurance keeps denying even after my appeals?
File a complaint with your state’s insurance commissioner. State regulators have authority over insurance companies and can pressure them to overturn denials. Include all your documentation, appeals letters, and evidence of medical necessity. Include the timeline of delays. Regulators take dementia cases seriously when they show that delays cause harm.
